JGR Capital Distributes Research Note on Foresight

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
60
JGR Capital Distributes Research Note on Foresight Autonomous (NASDAQ:FRSX)

NEW YORK, July 18, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – JGR Capital, an independent equity research firm, distributes an update note on Foresight Autonomous (NASDAQ: FRSX ), a development-stage technology company that develops powerful and mature proprietary stereoscopic technology.

The full report can be found here: bit.ly/2Npo3FH

Foresight Autonomous (“Foresight,” “FRSX” or the “Company”) is a development-stage technology company that develops stereoscopic technology derived from the field-proven security technology of its major shareholder, Magna BSP. The stereoscopic technology is an image processing concept that uses synchronized cameras to mimic human depth perception and obtain a 3D view. FRSX’s systems create and analyze 3D images to foresee possible collisions in roadway environments while providing real-time alerts with the lowest rates of false alerts. ​The Company’s proprietary stereoscopic and quad-camera technology is based in part on intellectual property that it has transferred from Magna BSP. Magna’s field-proven security technology has been deployed for almost two decades in critical facilities worldwide, including borders, nuclear plants and airports.

In June, the Company announced its first sale of a prototype of its QuadSight system for the semi-autonomous and autonomous vehicle market, which was sooner than expected. Additionally, for the Eye-Net V2X system, the Company completed a successful trial in collaboration with the City of Ashdod and NoTraffic Ltd.

 Key Report Highlights

  • The Company entered into a strategic merger agreement with Tamda for its Eye-Net subsidiary.
  • In late June, the company raised $12.4 million in capital from private placement.
  • Foresight Autonomous announced the first sale of its QuadSight prototype and MoU of sales for the Eyes-On ADAS System.

Disclosures pertaining to this Foresight Autonomous report can be found at www.jgrcap.com .

About Foresight Autonomous

Foresight Autonomous is an Israel-based automotive technology company engaged in the design, development, and commercialization of stereo/quad-camera vision systems based on three-dimensional (3D) video analysis, advanced algorithms and artificial intelligence for image processing and sensor fusion. FRSX develops systems for accident prevention, which are designed to provide real-time information about a vehicle’s surroundings while in motion. The Company targets two vertical markets, advanced driver assistance systems (ADAS) and autonomous/semi-autonomous vehicles, with its two key products of Eyes-On and QuadSight respectively. FRSX also develops and owns a cellular-based accident prevention system named Eye-Net. The Company is headquartered in Ness Ziona, Israel.

About JGR Capital

JGR Capital is an independent equity research firm with a focus on small-cap and pre-IPO companies under $2 billion in market cap. JGR Capital leverages a tech-forward approach to help these companies navigate the market by increasing visibility through equity research. With three locations worldwide, JGR Capital offers analyst coverage via a tech-forward, data-driven approach. Because our reports are based on facts, not recommendations, we are a reputable, trusted resource for investors. For more information, visit www.jgrcap.com

Disclosure

This press release may contain forward-looking statements, which involve risks and uncertainties. Actual results may differ significantly from such forward-looking statements. Factors that might cause such a difference include, but are not limited to, those discussed in the “Risk Factors” section in the SEC filings available in electronic format through SEC Edgar filings at www.SEC.gov .

The research analysts principally responsible for this press release do not receive compensation that is based upon any specific investment banking services or recommendations and can be compensated based on factors relating to the overall profitability of the JGR Capital (“firm”). As of the date of research distribution, neither the firm nor the principal research analysts beneficially own 1% or more of any class of common equity securities for this issuer (including, without limitation, any option, right, warrant, future, long or short position).

The securities of the issuer(s) discussed in this press release may be unsuitable for investors depending on their specific investment objectives and financial position. Past performance is no guarantee of future results. This research does not constitute a personal trading recommendation or take into account the particular investment objectives, financial situation or needs of an individual reader of this report and does not provide all of the pertinent information to make an investment decision.

Investor Contact

JGR Capital www.jgrcap.com   Email: research@jgrcap.com   Phone: 646-688-3143

Corporate Communications Contact: NetworkNewsWire (NNW) New York, New York www.NetworkNewsWire.com 212.418.1217 Office Editor@NetworkNewsWire.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 425

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 86

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 268

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 323

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 15

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 340

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading

Top 5 Most Recently Viewed Articles

Laugh Factory's Annual Free Thanksgiving Feast Returns to Hollywood

Updated Category News Views 239

Laugh Factory's Holiday Tradition: A Thanksgiving Feast The world-renowned Laugh Factory in Hollywood proudly continues its cherished tradition by hosting the 45th consecutive annual free Thanksgiving feast. This Thanksgiving, the club opens its doors for four seatings at 1 p.m., 3 p.m., 5 p.m., and 7 p.m., offering an incredible opportunity for community members to come...

Continue Reading
Recognizing Thomas Edwards Jr.: A Champion of Justice

Updated Category News Views 275

Celebrating Excellence in Legal Advocacy Attorney Thomas S. Edwards, Jr., a Senior Partner at Edwards & Ragatz, P.A., has been honored with the prestigious "Compassionate Gladiator Award" by the Florida Justice Association (FJA). This esteemed award is presented to legal professionals who exhibit exceptional dedication to their clients and the legal system, reflecting the...

Continue Reading
Growth Journey of Plant-Based Dairy: Trends and Insights

Updated Category News Views 283

Exploring the Plant-Based Dairy Products Market The plant-based dairy products market is witnessing remarkable growth, driven by evolving consumer preferences and increasing awareness regarding health benefits and sustainability practices. Initially valued at USD 20 billion, market experts project it to reach USD 34 billion by 2030, fueled by a promising CAGR of 9%...

Continue Reading
Catch the Excitement of Monster Jam at Northern Tool + Equipment

Updated Category News Views 138

Monster Jam Hits Northern Tool + Equipment in Oklahoma City Northern Tool + Equipment is thrilled to announce an upcoming event that promises to be packed with excitement and entertainment for the community. This special day will spotlight a legendary Monster Jam truck, bringing the high-octane thrill of motorsports to local fans. Exclusive Offers for Customers As part of...

Continue Reading
Analyzing NVIDIA’s Competitive Edge in Semiconductor Sector

Updated Category News Views 214

Understanding NVIDIA's Role in the Semiconductor Industry In the fast-paced world of technology, evaluation of companies within specific sectors is vital for investors and enthusiasts. This article focuses on NVIDIA (NASDAQ: NVDA), a leader in the Semiconductors & Semiconductor Equipment industry, and compares its performance with key competitors. By analyzing crucial...

Continue Reading